I
NTLA
Intellia Therape
12.96
+0.35+2.78%Opening09:45 05/27 EDT
OPEN/PREV CLOSE12.60/12.61
TODAY RANGE12.51-13.02
VOL465.44K
MARKET CAP1.81B
52 WEEK RANGE6.83-28.25
AVG VOL (3M)5.71M
% TURNOVER0.33%
TURNOVER--
P/E (TTM)-3.6675
% RANGE4.04%
EPS(TTM)-3.5337
P/E(FORWARD)-4.1406
P/B2.514
BVPS5.16
DIVIDEND--
P/S22.28
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.74B
SHARES OUTSTANDING139.72M
NEXT EARNINGS08/05-08/10
FREE FLOAT134.28M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/18 10:50
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM
TipRanks·05/14 12:09
J.P. Morgan Remains a Sell on Intellia Therapeutics (NTLA)
Dow Jones·05/13 18:49
Intellia Therapeutics Price Target Raised to $17.00/Share From $13.00 by Bernstein
Dow Jones·05/13 18:49
Intellia Therapeutics Is Maintained at Market Perform by Bernstein
Benzinga·05/13 13:03
Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Dow Jones·05/13 11:15
Intellia Therapeutics Is Maintained at Buy by HC Wainwright & Co.
TipRanks·05/13 10:28
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
TipRanks·05/13 08:54
Wells Fargo Remains a Hold on Intellia Therapeutics (NTLA)
Reuters·05/13 07:31
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Seeking Alpha·05/13 03:54
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Same Industry
Name/Symbol
Change%
Price